2.1
Ruxolitinib cream (Opzelura, Incyte) is indicated for 'the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age'.
2 Information about ruxolitinib
Marketing authorisation indication
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for ruxolitinib cream.
Price
2.3
The list price of ruxolitinib cream is £657.00 for a 100 g tube (Incyte website, accessed June 2024). The company has a commercial arrangement, which would have applied if ruxolitinib cream had been recommended.